Skip to main content
logo
Elicera Therapeutics AB (publ) (STO:ELIC)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.505
-0.090 (-3.47%)
Jul 24, 2026, 5:29 PM CET

Elicera Therapeutics AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
10.6410.867.1311.231.280
Revenue Growth
146.66%52.28%-36.52%777.23%217987.39%-
Gross Profit
10.6410.867.1311.231.280
Operating Income
-14.99-17.94-16.88-17.1-19.36-13.12
Net Income
-14.45-17.41-16.11-16.4-19.44-13.12
Earnings Per Share
-0.29-0.38-0.51-0.83-0.98-0.82
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash (Debt)
17.8624.8526.429.3843.8252.39
Net Cash Growth
-60.87%-5.88%-10.15%-32.95%-16.36%353.04%
Cash & Investments
17.8624.8526.429.3843.8252.39
Net Cash Per Share
0.370.540.841.491.882.93

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-17.71-21.55-23.46-14.92-8.57-13.11
Free Cash Flow
-17.71-21.55-23.46-14.92-8.57-13.11
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-140.95%-165.31%-236.86%-152.24%-1512.51%-2234990.00%
Pretax Margin
-135.89%-160.35%-226.01%-146.02%-1518.44%-2235169.17%
Profit Margin
-135.88%-160.35%-226.01%-146.02%-1518.44%-2235170.00%
FCF Margin
-166.52%-198.53%-329.16%-132.88%-669.50%-2233160.00%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
15.7223.348.228.0354.32169175.00